) operating results based on its reviewed consolidated financial statements ended 30 June 2019 as follows. Highlights on Q2-2019 Operating results Unit : Million Baht Q2-19 Q2-18 Q1-19 % Change Amount % Amount
DISCUSSION AND ANALYSIS FOR PERIOD ENDED 30 SEPTEMBER 2017 3. Financial highlights (based on Thai FRS) Q3 2017 Financial Position Summary as of 30 September 2017 compared to Q3 2016: Q3 2017 Q3 2016 YoY change
(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change Attention
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change - Update
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
55.74 million in 1Q19 from Baht 26.23 million in 1Q18. (Unit : Baht million) 31 MAR 19 (quarterly) 31 MAR 18 (quarterly) Change Revenues from Hospital Operations 200.01 139.21 43.68% Gross Profit 90.43
1Q19. (Unit : Million THB) 31 March 2020 (3 months period) 31 March 2019 (3 months period) Change Revenues from Hospital Operations 183.19 200.01 ‐8.41% Gross Profit 55.62 90.43 ‐38.49
confidence and higher household incomes. In early October, Bank of Thailand announced tighter mortgage rules in order to cool the property market and avoid the escalation of risks. Domestically, private